Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
22 hedge funds and large institutions have $11.4M invested in Alimera Sciences in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 13 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
31% less funds holding
Funds holding: 32 → 22 (-10)
39% less capital invested
Capital invested by funds: $18.8M → $11.4M (-$7.41M)
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$426K |
| 2 |
DMK
David M. Knott
|
+$87.3K |
| 3 |
RA
Royce & Associates
New York
|
+$19.9K |
| 4 |
Renaissance Technologies
New York
|
+$16.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$16.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$4M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.55M |
| 3 |
Morgan Stanley
New York
|
-$402K |
| 4 |
AC
Armistice Capital
New York
|
-$333K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$63K |
ALIM Hedge Fund Activity: Q4 2019 in Review
22 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q4 2019, worth a combined $11.4M — down 39% from $18.8M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ALIM and 3 opened new positions — a net loss of 10 holders — while 12 trimmed existing stakes and 6 added.
The largest buyer was Worth Venture Partners, adding an estimated $426K. The largest seller was Deerfield Management, exiting entirely with an estimated $4M sold.
- 22 institutional investors held Alimera Sciences (ALIM) as of Q4 2019, down from 32 in Q3 2019.
- Funds reported $11.4M of Alimera Sciences stock for Q4 2019, down 39% quarter-over-quarter.
- 3 funds opened new Alimera Sciences positions in Q4 2019 and 13 closed out, a net change of -10 holders.
- The largest Alimera Sciences buyer in Q4 2019 was Worth Venture Partners, an estimated $426K added.
- The largest Alimera Sciences seller in Q4 2019 was Deerfield Management, an estimated $4M sold.
Based on aggregated 13F filings for Q4 2019.